NCT03783910View on ClinicalTrials.gov

Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 19, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 20, 2006

Conditions
Primary Fibromyalgia
Interventions
DRUG

GRT9906

One prolonged-release tablet containing 40 mg of GRT9906

DRUG

Placebo

Placebo matching GRT9906 tablets

Trial Locations (6)

28210

005 Research Facility, Charlotte

32720

006 Research Facility, DeLand

78213

001 Research Facility, San Antonio

78229

003 Research Facility, San Antonio

97239

002 Research Facility, Portland

97504

004 Research Facility, Medford

Sponsors

Lead Sponsor

Grünenthal GmbH
All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY